| Dr Mark Marzouk, MD | |
|
750 Eadams Street, Syracuse, NY 13210 | |
| (315) 464-4636 | |
| Not Available |
| Full Name | Dr Mark Marzouk |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 23 Years |
| Location | 750 Eadams Street, Syracuse, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518293166 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MT189600 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Hospital S U N Y Health Science Center | Syracuse, NY | Hospital |
| Crouse Hospital | Syracuse, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Otolaryngology Associates Of Central New York, Llp | 0941109789 | 16 |
News Archive
In a study published November 20, 2013 in the New England Journal of Medicine1, researchers looked at the association of nut consumption with total and cause-specific mortality among 76,464 women in the Nurses' Health Study and 42,498 men in the Health Professionals Follow-up Study. Consumption of nuts, including tree nuts (such as pistachios, almonds, Brazil nuts, cashews, hazelnuts, macadamias, pecans, pine nuts, and walnuts), was inversely associated with total mortality in both men and women, independent of other predictors for death.
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Trypanosomes are single-celled parasites that cause diseases such as human African sleeping sickness and Nagana in animals. But they are also used in basic research as a model system to study fundamental biological questions.
Proteus Biomedical Inc., a pioneer in digital health, announced today that the United States Patent Office will award U.S. Patent Number 8114021 to Proteus. The patent, entitled "Body Associated Receiver and Method," is directed to the Proteus wearable and ingestible sensor technologies and related sensor devices used to create digital communication networks within, on and around the human body for health-related and other applications.
› Verified 5 days ago
| Entity Name | University Otolaryngology Associates Of Central New York, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497796361 PECOS PAC ID: 0941109789 Enrollment ID: O20031231000293 |
News Archive
In a study published November 20, 2013 in the New England Journal of Medicine1, researchers looked at the association of nut consumption with total and cause-specific mortality among 76,464 women in the Nurses' Health Study and 42,498 men in the Health Professionals Follow-up Study. Consumption of nuts, including tree nuts (such as pistachios, almonds, Brazil nuts, cashews, hazelnuts, macadamias, pecans, pine nuts, and walnuts), was inversely associated with total mortality in both men and women, independent of other predictors for death.
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Trypanosomes are single-celled parasites that cause diseases such as human African sleeping sickness and Nagana in animals. But they are also used in basic research as a model system to study fundamental biological questions.
Proteus Biomedical Inc., a pioneer in digital health, announced today that the United States Patent Office will award U.S. Patent Number 8114021 to Proteus. The patent, entitled "Body Associated Receiver and Method," is directed to the Proteus wearable and ingestible sensor technologies and related sensor devices used to create digital communication networks within, on and around the human body for health-related and other applications.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Marzouk, MD 750 E Adams St, Syracuse, NY 13210-2306 Ph: (315) 464-4636 | Dr Mark Marzouk, MD 750 Eadams Street, Syracuse, NY 13210 Ph: (315) 464-4636 |
News Archive
In a study published November 20, 2013 in the New England Journal of Medicine1, researchers looked at the association of nut consumption with total and cause-specific mortality among 76,464 women in the Nurses' Health Study and 42,498 men in the Health Professionals Follow-up Study. Consumption of nuts, including tree nuts (such as pistachios, almonds, Brazil nuts, cashews, hazelnuts, macadamias, pecans, pine nuts, and walnuts), was inversely associated with total mortality in both men and women, independent of other predictors for death.
Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.
Trypanosomes are single-celled parasites that cause diseases such as human African sleeping sickness and Nagana in animals. But they are also used in basic research as a model system to study fundamental biological questions.
Proteus Biomedical Inc., a pioneer in digital health, announced today that the United States Patent Office will award U.S. Patent Number 8114021 to Proteus. The patent, entitled "Body Associated Receiver and Method," is directed to the Proteus wearable and ingestible sensor technologies and related sensor devices used to create digital communication networks within, on and around the human body for health-related and other applications.
› Verified 5 days ago
Dr. William Michael Harmand, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-4633 | |
Dr. Alexandra Elizabeth Quimby, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-7281 Fax: 315-464-7298 | |
Anthony Joseph Mortelliti, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 750 E Adams St, Syracuse, NY 13210 Phone: 315-464-4633 | |
Erinn White, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3906 E Genesee St, Syracuse, NY 13214 Phone: 315-251-1093 Fax: 315-251-1571 | |
Dr. Ryan Winters, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 750 E Adams St, Suny Upstate Dpt Of Otolaryngology, Syracuse, NY 13210 Phone: 315-464-4636 | |
Adetokunbo Obayemi Jr., MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 750 East Adams Street, Cwb Rm 251, Syracuse, NY 13210 Phone: 201-431-5751 | |
Haidy Adly Marzouk, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 750 E Adams St, Dept. Of Otolaryngology, Syracuse, NY 13210 Phone: 315-464-5540 |